Literature DB >> 32313931

Functions of Gtf2i and Gtf2ird1 in the developing brain: transcription, DNA binding and long-term behavioral consequences.

Nathan D Kopp1,2, Kayla R Nygaard1,2, Yating Liu1,2, Katherine B McCullough1,2, Susan E Maloney2,3, Harrison W Gabel4, Joseph D Dougherty1,2,3.   

Abstract

Gtf2ird1 and Gtf2i are two transcription factors (TFs) among the 28 genes deleted in Williams syndrome, and prior mouse models of each TF show behavioral phenotypes. Here we identify their genomic binding sites in the developing brain and test for additive effects of their mutation on transcription and behavior. GTF2IRD1 binding targets were enriched for transcriptional and chromatin regulators and mediators of ubiquitination. GTF2I targets were enriched for signal transduction proteins, including regulators of phosphorylation and WNT. Both TFs are highly enriched at promoters, strongly overlap CTCF binding and topological associating domain boundaries and moderately overlap each other, suggesting epistatic effects. Shared TF targets are enriched for reactive oxygen species-responsive genes, synaptic proteins and transcription regulators such as chromatin modifiers, including a significant number of highly constrained genes and known ASD genes. We next used single and double mutants to test whether mutating both TFs will modify transcriptional and behavioral phenotypes of single Gtf2ird1 mutants, though with the caveat that our Gtf2ird1 mutants, like others previously reported, do produce low levels of a truncated protein product. Despite little difference in DNA binding and transcriptome-wide expression, homozygous Gtf2ird1 mutation caused balance, marble burying and conditioned fear phenotypes. However, mutating Gtf2i in addition to Gtf2ird1 did not further modify transcriptomic or most behavioral phenotypes, suggesting Gtf2ird1 mutation alone was sufficient for the observed phenotypes.
© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Year:  2020        PMID: 32313931      PMCID: PMC7526791          DOI: 10.1093/hmg/ddaa070

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  70 in total

1.  GTF2IRD1 in craniofacial development of humans and mice.

Authors:  May Tassabehji; Peter Hammond; Annette Karmiloff-Smith; Pamela Thompson; Snorri S Thorgeirsson; Marian E Durkin; Nicholas C Popescu; Timothy Hutton; Kay Metcalfe; Agnes Rucka; Helen Stewart; Andrew P Read; Mark Maconochie; Dian Donnai
Journal:  Science       Date:  2005-11-03       Impact factor: 47.728

2.  Heterozygous deletion of the Williams-Beuren syndrome critical interval in mice recapitulates most features of the human disorder.

Authors:  Maria Segura-Puimedon; Ignasi Sahún; Emilie Velot; Pierre Dubus; Cristina Borralleras; Ana J Rodrigues; María C Valero; Olga Valverde; Nuno Sousa; Yann Herault; Mara Dierssen; Luis A Pérez-Jurado; Victoria Campuzano
Journal:  Hum Mol Genet       Date:  2014-07-15       Impact factor: 6.150

3.  Action of TFII-I outside the nucleus as an inhibitor of agonist-induced calcium entry.

Authors:  Gabriela Caraveo; Damian B van Rossum; Randen L Patterson; Solomon H Snyder; Stephen Desiderio
Journal:  Science       Date:  2006-10-06       Impact factor: 47.728

4.  Mutation of Gtf2ird1 from the Williams-Beuren syndrome critical region results in facial dysplasia, motor dysfunction, and altered vocalisations.

Authors:  Monique L Howard; Stephen J Palmer; Kylie M Taylor; Geoffrey J Arthurson; Matthew W Spitzer; Xin Du; Terence Y C Pang; Thibault Renoir; Edna C Hardeman; Anthony J Hannan
Journal:  Neurobiol Dis       Date:  2011-12-11       Impact factor: 5.996

5.  Anxious, hypoactive phenotype combined with motor deficits in Gtf2ird1 null mouse model relevant to Williams syndrome.

Authors:  Tomasz Schneider; Zara Skitt; Yiwen Liu; Robert M J Deacon; Jonathan Flint; Annette Karmiloff-Smith; J Nick P Rawlins; May Tassabehji
Journal:  Behav Brain Res       Date:  2012-05-28       Impact factor: 3.332

6.  Anxiety, fears, and phobias in persons with Williams syndrome.

Authors:  Elisabeth M Dykens
Journal:  Dev Neuropsychol       Date:  2003       Impact factor: 2.253

7.  Reduced fear and aggression and altered serotonin metabolism in Gtf2ird1-targeted mice.

Authors:  E J Young; T Lipina; E Tam; A Mandel; S J Clapcote; A R Bechard; J Chambers; H T J Mount; P J Fletcher; J C Roder; L R Osborne
Journal:  Genes Brain Behav       Date:  2007-08-03       Impact factor: 3.449

8.  HTSeq--a Python framework to work with high-throughput sequencing data.

Authors:  Simon Anders; Paul Theodor Pyl; Wolfgang Huber
Journal:  Bioinformatics       Date:  2014-09-25       Impact factor: 6.937

9.  MeCP2, a key contributor to neurological disease, activates and represses transcription.

Authors:  Maria Chahrour; Sung Yun Jung; Chad Shaw; Xiaobo Zhou; Stephen T C Wong; Jun Qin; Huda Y Zoghbi
Journal:  Science       Date:  2008-05-30       Impact factor: 47.728

10.  SFARI Gene 2.0: a community-driven knowledgebase for the autism spectrum disorders (ASDs).

Authors:  Dan E Arking; Daniel B Campbell; Heather C Mefford; Eric M Morrow; Lauren A Weiss; Brett S Abrahams; Idan Menashe; Tim Wadkins; Sharmila Banerjee-Basu; Alan Packer
Journal:  Mol Autism       Date:  2013-10-03       Impact factor: 7.509

View more
  4 in total

1.  Innate frequency-discrimination hyperacuity in Williams-Beuren syndrome mice.

Authors:  Christopher M Davenport; Brett J W Teubner; Seung Baek Han; Mary H Patton; Tae-Yeon Eom; Dusan Garic; Benjamin J Lansdell; Abbas Shirinifard; Ti-Cheng Chang; Jonathon Klein; Shondra M Pruett-Miller; Jay A Blundon; Stanislav S Zakharenko
Journal:  Cell       Date:  2022-09-23       Impact factor: 66.850

2.  Shared developmental gait disruptions across two mouse models of neurodevelopmental disorders.

Authors:  Joseph D Dougherty; Susan E Maloney; Rachel M Rahn; Claire T Weichselbaum; David H Gutmann
Journal:  J Neurodev Disord       Date:  2021-03-20       Impact factor: 4.074

3.  Identification of disease-linked hyperactivating mutations in UBE3A through large-scale functional variant analysis.

Authors:  Kellan P Weston; Xiaoyi Gao; Jinghan Zhao; Kwang-Soo Kim; Susan E Maloney; Jill Gotoff; Sumit Parikh; Yen-Chen Leu; Kuen-Phon Wu; Marwan Shinawi; Joshua P Steimel; Joseph S Harrison; Jason J Yi
Journal:  Nat Commun       Date:  2021-11-23       Impact factor: 14.919

4.  Core transcriptional networks in Williams syndrome: IGF1-PI3K-AKT-mTOR, MAPK and actin signaling at the synapse echo autism.

Authors:  Li Dai; Robert B Weiss; Diane M Dunn; Anna Ramirez; Sharan Paul; Julie R Korenberg
Journal:  Hum Mol Genet       Date:  2021-04-30       Impact factor: 6.150

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.